Memory binding and white matter integrity in familial Alzheimer's disease by Parra, Mario A et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Memory binding and white matter integrity in familial Alzheimer's
disease
Citation for published version:
Parra, MA, Saarimäki, H, Bastin, ME, Londoño, AC, Pettit, L, Lopera, F, Della Sala, S & Abrahams, S 2015,
'Memory binding and white matter integrity in familial Alzheimer's disease' Brain, vol. 138, pp. 1355-1369.
DOI: 10.1093/brain/awv048
Digital Object Identifier (DOI):
10.1093/brain/awv048
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Peer reviewed version
Published In:
Brain
Publisher Rights Statement:
© This is a pre-copyedited, author-produced PDF of an article accepted for publication in Brain following peer
review. The version of record Parra, M. A., Saarimäki, H., Bastin, M. E., Londoño, A. C., Pettit, L., Lopera, F., ...
Abrahams, S. (2015). Memory binding and white matter integrity in familial Alzheimer's disease. Brain.
10.1093/brain/awv048 is available online at: http://brain.oxfordjournals.org/content/138/5/1355.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
 1 
 
Memory binding and white matter integrity in familial Alzheimer’s disease 
 
Mario A. Parra (1)(2)(3)(4)(5), Heini Saarimäki (1), Mark E. Bastin (2), Ana C. Londoño (5), Lewis 
Pettit (1), Francisco Lopera (5), Sergio Della Sala (1)(2) and Sharon Abrahams (1)(2)(6)  
 
 
 
Correspondence to: Mario A. Parra 
Human Cognitive Neuroscience, Psychology  
University of Edinburgh 
7 George Square 
Edinburgh EH8 9JZ - United Kingdom 
Phone: +44 (0) 131 650 8385 
Fax: +44 (0) 131 651 3230 
Email: mprodri1@staffmail.ed.ac.uk 
 
 
Running Title: Memory binding and white matter in FAD 
 
 2 
 
Abstract 
 
Binding information in short-term memory and in long-term memory are functions sensitive 
to Alzheimer’s disease. They have been found to be affected in patients who meet criteria for 
familial Alzheimer’s disease due to the mutation E280A of the PSEN1 gene. However, only 
short-term memory binding has been found to be affected in asymptomatic carriers of this 
mutation. The neural correlates of this dissociation are poorly understood. The present study 
used diffusion tensor MRI to investigate whether the integrity of white matter structures 
could offer an account. A sample of 19 familial Alzheimer’s disease patients, 18 
asymptomatic carriers and 21 non-carrier controls underwent diffusion tensor MRI, 
neuropsychological and memory binding assessment. The short-term memory binding task 
required participants to detect changes across two consecutive screens displaying arrays of 
shapes, colours, or shape-colour bindings. The long-term memory binding task was a Paired 
Associates Learning Test. Performance on these tasks were entered into regression models. 
Relative to controls, familial Alzheimer’s disease patients performed poorly on both memory 
binding tasks. Asymptomatic carriers differed from controls only in the short-term memory 
binding task. White matter integrity explained poor memory binding performance only in 
familial Alzheimer’s disease patients. White matter water diffusion metrics from the frontal 
lobe accounted for poor performance on both memory binding tasks. Dissociations were 
found in the genu of corpus callosum which accounted for short-term memory binding 
impairments and in the hippocampal part of cingulum bundle which accounted for long-term 
memory binding deficits. The results indicate that white matter structures in the frontal and 
temporal lobes are vulnerable to the early stages of familial Alzheimer’s disease and their 
damage is associated with impairments in two memory binding functions known to be 
markers for Alzheimer’s disease.  
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Introduction 
 
Although Alzheimer’s disease appears to grossly impair integrative memory functions both in 
short-term memory (STM) (Della Sala et al. 2012; Parra et al., 2009; 2011) and in long-term 
memory (LTM) (Buschke et al., 1999; O'Connell et al., 2004; Swainson et al., 2001), these 
impairments seem to have different origins. STM binding supports the temporary retention of 
conjunctions of features within object representations, a function needed for the formation of 
new identity. Associative learning (i.e., LTM binding) enables a flexible representation of the 
relations between the stimulus’ parts, each holding its own identity and retaining its 
individual access (Mayes et al., 2007; Moses and Ryan, 2006).  
STM binding deficits have been observed in asymptomatic carriers of the mutation E280A of 
the PSEN1 gene (E280A-PSEN1) who still perform normally on LTM binding tasks, such as 
the Paired Associates Learning (PAL) test of Wechsler Memory Scale (Wechsler, 1997) which 
has been found to be sensitive to prodromal and clinical Alzheimer’s disease (Duchek et al., 
1991; Elias et al., 2000). In fact, STM and LTM binding deficits in these individuals do not 
correlate (Parra et al., 2011) reinforcing the notion of different neural substrates. Whereas 
LTM binding relies on the integrity of cerebral grey matter structures such as the 
hippocampus, which is known to be targeted by Alzheimer’s disease in its sporadic 
(Echavarri et al., 2010) and familial variants (Quiroz et al., 2010), a recent functional MRI 
(fMRI) study indicates that the STM binding function investigated below does not (Parra et 
al., 2014). Recent behavioural studies have further expanded the evidence in favour of 
dissociations between these two types of memory representation (Parra et al., 2013). 
The STM binding task asks participants to hold together in memory features processed in 
separate brain regions whereas the LTM binding task (i.e., PAL) asks participants to learn the 
association between two words. These tasks require effective brain connectivity (Genon et 
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al., 2013; Koenig et al., 2005; O'Reilly et al., 2003). It is well recognized that Alzheimer’s 
disease leads to a disconnection syndrome (Bozzali et al., 2011; Gili et al., 2011), and it is 
therefore hypothesized that such a syndrome underlies this specific cognitive deficit.  
An Alzheimer’s disease disconnection syndrome has been well characterised using EEG-
based methods (Cook and Leuchter, 1996; Dunkin et al., 1994) and more recently by resting 
state fMRI (Buckner et al., 2005; Buckner et al., 2008). Abnormal patterns of brain 
connectivity in the default mode network appear to characterise the transition from normal 
ageing to mild cognitive impairment (MCI) and from MCI to Alzheimer’s disease (Miao et 
al., 2011; Pihlajamaki and Sperling, 2009). Furthermore connectivity deficits as assessed by 
electrophysiological and neuroimaging techniques significantly correlate with cognitive 
decline both in prodromal (Chua et al., 2008) and clinical Alzheimer’s disease (Duan et al., 
2006; Medina and Gaviria, 2008). However, the precise contribution of grey and white matter 
disruptions to the disconnection syndrome, and its cognitive implications, remains unclear 
(Johnson et al., 2010; Oishi et al., 2011).  
Abnormalities in white matter integrity can now be more precisely investigated in vivo using 
diffusion tensor MRI (DT-MRI; Basser, 1995), and have been used to investigate the 
underpinnings of cognitive deterioration in individuals at increased risk for Alzheimer’s 
disease such as those with MCI (Bozzali et al., 2011; Chua et al., 2008; Stebbins and 
Murphy, 2009). These studies are characterised by a great variability in the localization of 
abnormalities within white matter tracts in MCI patients, e.g. in medial temporal lobe 
(Fellgiebel et al., 2004; Kantarci et al., 2005), projection fibres including posterior cingulum, 
thalamic radiations and fornix (Kiuchi et al., 2009; Zhuang et al., 2010), association fibres 
including superior and inferior longitudinal fasciculi and inferior fronto-occipital fasciculus 
(Medina et al., 2006; Zhuang et al., 2010), and white matter underlying frontal, temporal, 
parietal and occipital lobes (Douaud et al., 2011; Medina et al., 2006; Zhuang et al., 2010). 
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Nevertheless, recent evidence suggests that these abnormalities are related to cognitive 
decline in MCI patients and seem to develop very early along with still subtle grey matter 
damage (Bozzali et al., 2011; Gili et al., 2011; Sexton et al., 2011).  
Studies of preclinical cases of familial Alzheimer’s disease have also revealed decreased 
white matter integrity in columns of the fornix and left orbitofrontal lobe in mutations carriers 
who have gone on to develop familial Alzheimer’s disease , i.e. PSEN1, mutations A431E, 
L235V, G206A and V717I (Ringman et al., 2007). These patients were completely 
asymptomatic (Clinical Dementia Rating = 0, cognitively unimpaired) at the time of 
assessment indicating that reduced white matter integrity may precede the development of 
clinical symptoms (Ukmar et al., 2008; Wang et al., 2012). Similar disruptions are also 
observed in other non-Alzheimer’s disease dementias (Borroni et al., 2007; Sweed et al., 
2012), suggesting that DT-MRI alone may lack specificity in early identification of 
Alzheimer’s disease. However, identifying early DT-MRI abnormalities associated with 
memory binding impairments, which are known to be sensitive to Alzheimer’s disease, would 
help overcome this limitation. If this hypothesis proves valid, combining assessment of DT-
MRI and memory binding performance may unveil brain abnormalities which are more 
closely related to Alzheimer’s disease pathology. The present study therefore firstly 
investigated whether differences in white matter integrity detected with DT-MRI are related 
to STM binding deficits in carriers of the mutation E280A- PSEN1 who were either 
asymptomatic or had recently met criteria for Alzheimer’s disease. Secondly the study 
compared regional DT-MRI metrics with performance on both STM binding and LTM 
binding tasks to investigate further the neural dissociation between these two processes. 
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Methods 
Participants 
The participants were members of a large kindred from the Colombian province of Antioquia, 
South America. They carry the gene mutation E280A of presenilin-1 which invariably leads 
to an autosomal dominant early-onset familial Alzheimer’s disease. This variant of familial 
Alzheimer’s disease becomes clinically detectable at 47 years of age, on average; see (Lopera 
et al., 1997) for a clinical description. Mutation carriers either in the symptomatic or pre-
symptomatic stages of the disease, along with members their family, regularly attend clinical 
and research appointments at the Health Unit of the Neuroscience Centre of the University of 
Antioquia. This Health Unit has been monitoring this population for more than 20 years. The 
participants were approached by the responsible consultants who introduced the study and 
invited them to take part. All the patients who attended the Unit during the time of the study 
were given the opportunity to participate. Moreover, patients and relatives who had 
previously expressed an interest in research and whose contact details were held in the 
centre’s database were also contacted. Only those expressing an interest were taken forward 
to the enrolment process which began with the informed consent. The genetic status of these 
patients is unknown to the centre’s staff and was not revealed to members of the research 
team until the recruitment process had been completed. This was done using anonymous 
codes. The study protocol was approved by the Ethics Committee at University of Antioquia, 
Colombia. 
The assessment protocol for all the participants consisted of three phases. First, participants 
who were not in the centre database (new to the Centre) underwent genetic screening to 
confirm or exclude the presence of the mutation using the methodology reported by the 
Alzheimer’s disease Collaborative Group (Clark et al., 1995). Second, all the participants 
underwent neurological and neuropsychological assessments carried out by expert clinicians 
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and neuropsychologists. Third, all the participants underwent DT-MRI assessment. The first 
two phases allowed us to allocate participants to three groups: 1) participants with familial 
Alzheimer’s disease caused by the E280A single presenilin-1 mutation, 2) carriers of the 
mutation who did not meet Alzheimer’s disease criteria and who were asymptomatic at the 
time of testing, and 3) healthy individuals who did not carry the gene mutation, were healthy 
as confirmed by the clinical interview and were relatives of the members of the other two 
groups (healthy controls).  
A sample of 58 participants entered the study. Data from 32 participants (HC = 6, AC = 16, 
FAD = 10) were drawn from previous studies investigating visual STM (VSTM) binding 
(Parra et al., 2010; 2011). The other new participants were assessed with the same protocol. 
The first group comprised 19 familial Alzheimer’s disease  patients diagnosed according to 
the criteria established by the Diagnostic and Statistical Manual of Mental Disorders (4th 
edition, text revision), and the National Institute of Neurological and Communicative 
Disorders and Stroke and the Alzheimer’s Disease and Related Disorders Association 
(NINCDS-ADRDA) group (McKhann et al., 1984). Second, the asymptomatic carriers group 
consisted of 18 participants who met neither Alzheimer’s disease nor MCI criteria at the time 
of the testing but who were positive for the E280A mutation. Third, the healthy controls 
group included 21 non-carriers who were relatives of the familial Alzheimer’s disease 
patients and asymptomatic carriers. Additional inclusion criteria for the control participants 
included 1) negative history of neurological or psychiatric disorders, 2) a Mini-Mental State 
Examination (MMSE) score equal or greater than 24, and 3) no memory complaints as 
documented by a self-report and family questionnaire.   
Asymptomatic carriers and healthy controls were matched according to age, the number of 
years spent in formal education, and the MMSE scores (see Table 1). On average, familial 
Alzheimer’s disease patients were older and less educated than the two other groups.  
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---------------------------------------------- 
Insert Table 1 about here 
---------------------------------------------- 
 
Each participant underwent a colour vision assessment using Dvorine pseudo-isochromatic 
plates (Dvorine, 1963) and a binding perception condition. These assessments were 
undertaken to rule out the possibility that poor performance on the STM binding task could 
result from visual or perceptual difficulties. None of the participants recruited for the present 
study were excluded due to colour vision or perceptual binding problems.  
 
Behavioural Assessment  
Neuropsychological battery 
The neuropsychological battery comprised Spanish translations of the MMSE (Ardila et al., 
2000), the PAL  task (Wechsler, 1997), Verbal (Letter-FAS, adapted from Sumerall et al., 
1997) and Animal Fluency tests (from Morris et al., 1989), the Copy and Recall of the 
Complex Figure of Rey-Osterrieth (Osterrieth, 1944), Part-A of the Trail Making test (Reitan, 
1958), the Boston Naming test (Kaplan et al., 1983), the Wisconsin Card Sorting test (WCST; 
Berg, 1948), and the Word List test (from Morris et al., 1989).  
 
Visual short-term memory task  
The VSTM task assessed memory for shapes (see Figure 1a), colours, or combinations of the 
two. Stimuli were randomly selected from a set of eight shapes and eight colours and 
presented as individual features or as features combined into integrated objects. Each type of 
stimulus was presented in a separate condition. Three experimental conditions were used (see 
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Figure 1b), each consisting of 15 practice trials followed by 32 test trials leading to a total of 
96 test trials per task. Trials were fully randomized across participants and conditions were 
delivered in a counter-balanced order. In the `Shape only’ and `Colour only’ conditions, 
arrays of shapes or colours were presented in the study display. In the test display for the 
`different’ trials, two new shapes or colours from the study array were replaced with two new 
shapes or colours. Hence, in these conditions, only VSTM for individual features was 
required to detect a change. In the `Shape-colour binding’ condition, combinations of shapes 
and colours were presented in the study display. In the test display for `’different’ trials, two 
shapes swapped the colours in which they had been shown in the study display. Hence, 
memory for bindings of shape and colour in the study display was required in order to detect 
this change. No shape or colour was repeated within a given array. 50% of the test trials were 
`same’ trials (the study and test displays presented identical items) and 50% were ’different’ 
trials. 
 
---------------------------------------------- 
Insert Figure 1 A and B about here 
---------------------------------------------- 
 
Trials began with a fixation screen presented for 500 ms. This was followed by an array 
presented for 2000 ms on a 15” PC screen using a 3 x 3 virtual grid ('study display'). After a 
900 ms retention interval, participants were presented with ‘test display’ and were required to 
respond orally whether the test stimulus was the 'same' or 'different' to the one presented in 
the ‘study display'. The experimenter entered participants’ responses using the keyboard. 
Memory load was manipulated to match the general group performance by presenting 
asymptomatic carriers and healthy controls with arrays of three items and familial 
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Alzheimer’s disease patients with arrays of two items. Previous studies have shown that 
manipulating the memory loads allows performance levels in the baseline memory condition 
to be equated across groups and, thus, any differences between groups in VSTM binding 
performance cannot be attributed to the baseline differences in memory for single features 
(Parra et al., 2010).  
 
DT-MRI Assessment  
Data collection and pre-processing  
DT-MRI data were collected using a Siemens Symphony Vision 1.5 T (Siemens Healthcare 
Sector, Erlangen, Germany) clinical scanner, and consisted of one T2-weighted and sets of 
diffusion-weighted (b = 1000 s/mm2) single-shot, spin-echo, echo-planar (EP) volumes 
acquired with diffusion gradients applied in 12 non-collinear directions. Fifty contiguous 
slice locations were imaged with a field-of-view of 220 × 220 mm, an acquisition matrix of 
128 × 128 and a slice thickness of 3 mm, giving an acquisition voxel dimension of 1.72 × 
1.72 × 3 mm. The repetition and echo times for each EP volume were 7.2 s and 90 ms.  
The DICOM format (http://medical.nema.org) magnitude images were converted into NIfTI-
1 format (http://nifti.nimh.nih.gov). Using tools freely available in FSL (FMRIB, Oxford, 
UK; http://www.fmrib.ox.ac.uk), the DT-MRI data were pre-processed to extract the brain, 
and bulk patient motion and eddy current induced artefacts removed by registering the 
diffusion-weighted to the T2-weighted EP volume for each subject (Jenkinson and Smith, 
2001). From these MRI data, mean diffusivity (D) and fractional anisotropy (FA) volumes 
were generated for every subject using DTIFIT.  
 
ROI placement  
Semi-automated region-of-interest (ROI) analysis was performed using ’in house’ software 
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written in MATLAB (The MathWorks, Natick, MA, USA) that allowed multiple small square 
ROIs to be placed on the T2-weighted EP volumes and then overlaid on the co-registered D 
and FA maps automatically using locations defined in Montreal Neurological Institute (MNI; 
http://www.bic.mni.mcgill.ca) standard space. The software allows the user to interactively 
move ROIs if standard to native space registration errors cause white matter ROIs to be 
placed over cerebrospinal fluid (CSF) or grey matter structures. 
The procedure for obtaining the FA and D values for each ROI is presented in Figure 2A. 
First, MNI coordinates were defined in standard space for each ROI using the ICBM-DTI-81 
white matter atlas (Oishi et al., 2011) and then selected in FSLview 3.1.8.  Either 4, 6 or 12 
square ROIs were defined for each brain structure depending on its size in horizontal view, 
sizes of which were 3 x 3 x 1 voxels (see Supplementary Table 1 for MNI coordinates of each 
ROI and Supplementary Table 2 for parameters used to place ROIs). Differences in size of 
the chosen ROI are explained by anatomical factors (e.g., tract dimension as for the 
corticospinal tract) and underlying theory (e.g., middle frontal white matter which 
encompasses tracts found to be impaired in Alzheimer’s disease). An aim of this study was to 
unveil biomarkers of cognitive impairment in preclinical Alzheimer’s disease. We therefore 
maximized the likelihood of identifying DTI correlates of behavioural impairments. 
Several square ROIs were used for each structure in order to reduce the effects of differences 
in individual placement. Next, the coordinates were mapped from standard space to each 
individual’s T2-weighted EP volume using the inverse of the transformation matrix from 
native to standard space (MNI152_T1_1mm_brain template) determined using affine 
registration (12 degrees of freedom) provided by FSL’s FLIRT. The placement of the ROIs in 
native space was then checked to ensure no overlap with either CSF or grey matter. The T2-
weighted EP volumes were used to define the ROIs to avoid biasing their placement by the 
underlying FA and D values; see (Bozzali and Cherubini, 2007). Minor adjustments to ROI 
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position were performed by an investigator blind to subjects’ genetic or clinical status. It was 
only to some ROIs whenever they fell into CSF or grey matter. Finally, the values for FA and 
Dwere obtained for each square and then averaged for each ROI separately.  
We chose ROIs which met two criteria. First, they comprise tracts relevant to the specific 
memory functions investigated in this study and second, they have been found to be affected 
in the preclinical and in the clinical stages of Alzheimer’s disease. The ROIs targeted by the 
Alzheimer’s disease pathology (e.g., amyloid plaques) in the preclinical stages were of 
particular interest (Buckner et al., 2005; Fleisher et al., 2012). The selected ROIs that met 
these criteria are shown in Figure 2B (see also Supplementary Table 1 for the MNI 
coordinates). They included two regions of the corpus callosum, the genu (central body) 
corresponding to forceps minor (gCC, Fig 2B-(a)) and the splenium which includes the 
forceps major (sCC, Fig 2B-(b)), both interhemispheric tracts. Two regions were selected 
from the frontal lobes. One labelled middle frontal white matter (mFWM, Fig 2B-(c)) which 
encompasses the inferior frontal-occipital fasciculus, the anterior thalamic radiations and the 
lateral projections of the genu which run ipsilaterally. The other was a more inferolateral 
region of the frontal white matter through which runs the superior longitudinal fasciculus 
(iFWM, Fig 2B-(d)). In the medial temporal lobe we selected the hippocampal part of the 
cingulum bundle (CGH, Fig 2B-(e)). White matter tracts, including cingulum, bilateral 
superior frontal-occipital fasciculus, and the genu of the corpus callosum are known to 
connect regions of the default mode network (DMN) (Teipel et al., 2010) which have been 
consistently found to be affected by Alzheimer’s disease (Agosta et al., 2011; Sorg et al., 
2009; Wu et al., 2011). Furthermore, regions of the DMN, such as the frontal lobes, are 
associated with working memory performance (Koshino, Minamoto, Yaoi, Osaka, & Osaka, 
2014) whereas medial temporal lobe regions are involved in long-term associative memory 
functions (Ward et al., 2014). These regions have shown a synergistic relationship following 
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brain damage (Maccotta et al., 2007).  The final ROI we considered was the centrum 
semiovale (CS, Fig 2B-(e)) which covers large areas of the corticospinal tract. This was 
chosen on the assumption of preserved motor functions in the early stages of Alzheimer’s 
disease (Huang et al., 2012; Rose et al., 2000) and as such served as a comparative control 
region. One other region found to be relevant in previous DT-MRI studies involving 
preclinical Alzheimer’s disease is the fornix (Molinuevo et al., 2014; Racine et al., 2014; 
Ringman et al., 2007). This is a projection tract which connects the medial temporal lobe to 
other limbic structures and is known to be involved in memory functions (Boespflug et al., 
2014). However, technical limitations (i.e., small size and imprecise boundaries) prevented 
the inclusion of this ROI in our analysis. Nevertheless, we included the CGH, a white matter 
tract linking the hippocampus and para-hippocampal cortex to the posterior cingulate cortex, 
known to be relevant for memory function and sensitive to Alzheimer’s disease pathology 
(Catheline et al., 2010; Villain et al., 2008).  
Finally, ROI selection was independently performed by two investigators of this study. The 
aim of this procedure was to assess inter-rater reliability of region of interest placement. To 
this aim, rater 2 (MB) randomly selected a subset of participants (n=5) from the dataset 
initially processed by rater 1 (HS). We report on the index of reproducibility and coefficient 
of variation for the two DT-MRI metrics. 
 
---------------------------------------------- 
Insert Figure 2 A and B about here 
---------------------------------------------- 
 
Statistical analyses  
Statistical analyses were performed in R version 3.1.1 (R Development Core Team). Group 
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differences in background variables (e.g., age, education, and MMSE score) were examined 
with ANOVA using Tukey's test for post-hoc comparisons. Hemispheric differences in FA and 
D values were examined with t-tests.  
Group differences in behavioural tasks were tested with linear regression. A model with age, 
education, and group was created for each task (task ~ age + education + group) to test for the 
relationship between these variables and task performance. Post-hoc group comparisons were 
performed with using pairwise least-squares means comparison with the Tukey's correction 
for multiple comparisons using lsmeans function from the lsmeans package. Least-squares 
means were used in order to extract the group means after controlling for age and education 
effects. 
Group differences in DT-MRI metrics (i.e., FA and D values) for each ROI were examined 
with linear regression. A simple model with group as a predictor was created for each ROI 
(DT-MRI ~ group) and post-hoc group comparisons were performed with pairwise Tukey's 
test. This model, and the subsequent models in which group was entered as a predictor, allow 
the assessment of associations between dependent variables (i.e., DT-MRI measures and 
behavioural) and group membership. The rationale behind these regression models is that 
they fit the first intercept and slope for the association between such variables in the first 
group (in our analysis this was the healthy control group). Then, the models test whether 
group membership (i.e., asymptomatic carriers or familial Alzheimer’s disease  patients) 
modifies such associations. The relationship between task performance and DT-MRI metrics 
was investigated with linear regression by fitting models with DT-MRI variables as 
predictors for task performance (task ~ DT-MRI).  
Finally, the relationship between task performance, DT-MRI variables, and group 
membership was examined with correlation and linear regression. Firstly, we examined the 
correlation between task performance and DT-MRI variables in each ROI separately in all 
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groups. Second, to visualize the results, we examined the significant correlations revealed in 
step one more closely with linear regression. The relationship between task performance, 
group identity and DT-MRI parameters was investigated with linear regression by predicting 
task performance with group identity, DT-MRI parameter, and their interaction (task ~ group 
* DT-MRI). To account for multiple statistical comparisons, all p-values shown were False 
Detection Rate (FDR) corrected. 
A recent study confirmed that the method reported here to place ROIs and derive DT-MRI 
variables provides good reliability (Pettit et al., 2013). However, we performed further inter-
rater reliability analysis for the ROIs chosen for the present study. To this aim, placement of 
the ROIs was independently performed by two investigators of this study. Rater 2 (LP) 
randomly selected a subset of participants (n=5) from the dataset initially processed by rater 1 
(HS). We report on the index of reproducibility and coefficient of variation for the two DT-
MRI variables. 
 
Results  
Behavioural results  
Results from group comparisons of behavioural variables are presented in Table 2. Familial 
Alzheimer’s disease patients performed significantly worse than healthy controls on all 
neuropsychological and VSTM binding tasks except for the WCST and Letter fluency task. 
Familial Alzheimer’s disease patients performed significantly worse than the asymptomatic 
carriers on all tasks except for the WCST and colour-colour binding task. Asymptomatic 
carriers performed significantly worse than healthy controls on the shape-colour binding 
condition of the VSTM task only.  
Education was associated with task performance on the Trail Making Test, Animal Fluency, 
and Boston Naming Test. Age was not significantly associated with performance in any of the 
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tasks. Importantly, age and education were not associated with VSTM shape-colour binding 
or PAL tasks, so further analyses with these tasks of interest did not include age or education 
as a covariate. 
 
---------------------------------------------- 
Insert Table 2 about here 
---------------------------------------------- 
 
DT-MRI metrics  
The inter-rater reliability analysis indicated excellent reproducibility of ROI measurements 
with the standard deviation of the difference between repeated measures of D and FA being 
37 x 10-6 mm2/s (mean of measurements 739 x 10-6 mm2/s) and 0.034 (mean 0.349), 
respectively. This yielded coefficients of variation of 5.0% for D (range 0.0 for CS to 8.51% 
for CGH) and 9.8% for FA (range 0.0 for CS to 12.3% for CGH), which compares well with 
values for other studies using ROI analysis (Shenkin et al., 2005). 
Initial comparisons between FA and D values from corresponding ROIs in left and right 
hemispheres revealed hemispheric differences in all regions either in FA, D, or both. 
Therefore, all the reported analyses were conducted for hemispheres separately (Table 3). 
Group comparisons between asymptomatic carriers and controls revealed no significant 
differences in either FA or Dvalues. However, group comparisons between familial 
Alzheimer’s disease patients and controls showed that familial Alzheimer’s disease patients 
had higher D in CGH and GCC bilaterally, left iFWM, and left sCC. Also, group 
comparisons between familial Alzheimer’s disease patients and asymptomatic carriers 
showed that familial Alzheimer’s disease patients had higher Din gCC bilaterally, left 
iFWM, right CGH, and left sCC.  
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Relationship between DT-MRI metrics and behavioural tasks  
To identify the ROIs which might be related to deficits in STM binding, the shape-colour 
binding condition was chosen for further analysis as this was the only condition of the STM 
binding task that differentiated between the three study groups. Performance on the PAL task 
was also included for comparison due to the reported sensitivity of this memory function to 
the early stages of Alzheimer’s disease (Fowler et al., 2002; Swainson et al., 2001). Although 
in the current study asymptomatic carriers were not significantly impaired on the PAL, in 
previous studies this task accounted for a large proportion of variance between carriers and 
controls who were taken from the same population (Parra et al., 2010). Our data show a 
significant group effect in the shape-colour binding task (model P < 0.001, adjusted R2 = 
0.42) and PAL task (model P < 0.001, adjusted R2 = 0.43).  
In the shape-colour binding task, better performance was significantly predicted by D values 
in bilateral gCC and, left iFWM, and left CGH (Table 4). FA values did not significantly 
predict task performance. When examining the groups separately, we found that task 
performance correlated significantly with Dvalues in right mFWM (r = -0.80, P = 0.036) 
and left gCC (r = -0.75, P = 0.04) only in the familial Alzheimer’s disease group (Figure 3). 
In the other groups the correlations were not significant (see Supplementary Table 3). The 
task ~ group*DT-MRI model with variables showing significant correlations revealed that 
the slope of the familial Alzheimer’s disease group significantly differed from that of controls 
for both mFWM and bilateral gCC (all P < 0.05).  
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In the PAL task, better performance was significantly predicted by FA values in left mFWM, 
right sCC, left CGH, and by D values in all ROI but right iFWM and right CS (see Table 4). 
When examining the groups separately, we found that task performance correlated 
significantly with FA values in left mFWM (r = 0.85, P = 0.002) and with D values in left 
mFWM (r = -0.69, P = 0.036), right mFWM (r = -0.66, P = 0.048), left iFWM (r = 0.70, P = 
0.036), and left CGH (r = -0.72, P = 0.036) in the familial Alzheimer’s disease group (Figure 
3). Although the correlations in the AC group were all non-significant, the effect sizes were 
of middle or large magnitude as compared with small in the HC group (see supplementary 
table 3). The task ~ group*DT-MRI model with variables showing significant correlations 
revealed that the slope of the familial Alzheimer’s disease group significantly differed from 
that of controls for FA values in left mFWM, Din left mFWM, left iFWM, and left CGH 
(all P < 0.05). 
 
Discussion 
 
The present study was designed to investigate whether white matter integrity detected with 
DT-MRI was associated with deficits in memory binding functions known to be sensitive to 
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the early stages of Alzheimer’s disease. This hypothesis was assessed in a unique population 
of carriers of the mutation E280A- PSEN1 who were either in the asymptomatic stages or had 
recently met criteria for Alzheimer’s disease. The main findings of this study were: (1) white 
matter integrity in frontal regions (mFWM) and in the anterior part of corpus callosum (gCC) 
accounted for a significant proportion of variance of STM binding performance. (2) White 
matter integrity in frontal regions (mFWM and iFWM) and in the hippocampal part of 
cingulum bundle (CGH) accounted for a significant proportion of variance in performance on 
the PAL task. (3) These associations proved significant in the clinical but not in the 
preclinical stages of familial Alzheimer’s disease. Before we discuss the implications of these 
findings for our current understanding of memory decline in Alzheimer’s disease, we briefly 
address the distinction between these two memory systems.  
STM binding is an integrative memory function known to support the conjunction of features 
necessary to create objects’ identity (Staresina and Davachi, 2010). Such a function relies on 
regions along the visual ventral stream but is independent of the hippocampus (Parra et al., 
2014). Associative memory is an integrative memory function responsible for linking aspects 
of complex experiences, each with own identity, into relational representations. Such a 
memory function cannot be carried out without an intact hippocampus (Mayes et al., 2007; 
Moses and Ryan, 2006). Conjunctive (STM binding) and relational (associative memory) 
binding functions have been found to dissociate also in STM (Parra et al., 2013). A recent 
hypothesis paper has suggested that context-free memory (e.g., STM binding) declines in the 
sub-hippocampal phase of Alzheimer’s disease, which seems to occur very early in the 
disease process (Braak stages I-II). However, context-rich memory (e.g., associative memory) 
is impacted during the hippocampal phase of Alzheimer’s disease which appears to 
correspond to more advanced diseases stages (Braak stages III-VI) (Didic et al., 2011). This 
ongoing debate is relevant to our current study as our data revealed different patterns of 
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dissociation for behavioural and DT-MRI variables. 
Unlike previous studies which have consistently reported differences in white matter integrity 
in the pre-symptomatic stages of familial Alzheimer’s disease (Ringman et al., 2007; Ryan et 
al., 2013), in the present study we failed to find significant differences in DT-MRI metrics 
between asymptomatic carriers and controls. There are some key differences between the 
present study and those reported earlier which may explain this lack of replication. First, 
Ringman et al. (2007) investigated DT-MRI metrics in a heterogeneous group of carriers of 
different mutations either in the PSEN1 (A431E, n=11; L235V, n=7; G206A, n= 1) or APP 
gene (V717I, = 4). This raises the question of whether such diverse genotypes may yield 
phenotypic expressions which contributed differently to the reported outcomes. In our study 
we assessed a sample taken from a population which carries a single mutation of the PSEN1 
(i.e., E280A). Second, in the study by Ryan et al. (2013), they investigated an even more 
genetically heterogeneous sample of carriers of PSEN1 mutation who were also older than 
the carriers investigated in the present study (M=37.8, SD=4.7). Age is an important factor in 
these dominantly inherited forms of Alzheimer’s disease as it unequivocally indicates time to 
clinical expression. It has been recently observed that the PSEN1 mutation affecting the 
individuals from the Colombian kindred (i.e., E280A) leads to accumulation of amyloid 
deposits from 28 through 37 years of age (Fleisher et al., 2012). The asymptomatic carriers 
investigated here had a mean age of 35. The contributions of the amyloid pathology to white 
matter disruptions in Alzheimer’s disease are well known (Racine et al., 2014). These earlier 
findings together with our current results suggest that our sample of E280A- PSEN1 mutation 
carriers was in a stage of preclinical familial Alzheimer’s disease where structural damage to 
white matter tracts is not yet evident.  
Consistent with previous studies (Parra et al., 2010; 2011), mutation carriers who did and did 
not meet criteria for familial Alzheimer’s disease presented with significant STM binding 
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impairments. However, we observed that lower white matter integrity values were associated 
with STM binding impairments only in symptomatic carriers of the E280A- PSEN1 mutation. 
These differences were driven by increased D in frontal white matter and gCC. One other 
study investigating white matter integrity in familial Alzheimer’s disease of which we are 
aware (Ringman et al., 2007), showed disruption in left frontal white matter (ROI specified 
as two voxels in inferior frontal white matter). Although Ringman et al. (2007) implemented 
a definition of frontal white matter different from our own, our results are complementary and 
suggest that frontal white matter disturbances is an early anatomical signature of Alzheimer’s 
disease (see also Oishi et al., 2011). Furthermore the present study indicates that these white 
matter differences are associated with a decline of memory functions known to be affected in 
the preclinical stages of the disease, namely STM binding.   
The role of frontal lobes (and connecting structures such as gCC) in working memory (Owen, 
2000) and in binding functions in particular (Prabhakaran et al., 2000; Sala and Courtney, 
2007) has been recognized. Neuroimaging studies have documented the involvement of 
frontal regions, e.g. BA10 and dorso-lateral prefrontal cortex, during feature binding in 
working memory (Mitchell et al., 2006; Prabhakaran et al., 2000) and have suggested that 
changes in the activity of these regions are related to reduced binding abilities in older adults 
(Mitchell et al., 2006). Here this association is further strengthened with the finding of 
prefrontal tract abnormalities related to STM binding deficits in individuals who have 
recently met criteria for familial Alzheimer’s disease. Neuronal degeneration in Alzheimer’s 
disease seems to begin in the neuronal periphery rather than in the cell body (Pigino et al., 
2003; Stokin et al., 2005), and these early abnormalities appear to be associated with amyloid 
pathology (Gunawardena and Goldstein, 2001; Racine et al., 2014). Factors such as altered 
myelin and oligodendrocytes, axonal degeneration, and vascular pathologies, are some 
proposed mechanisms (Bartzokis I et al., 2007; Englund and Brun, 1990; Sjobeck et al., 
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2005).  
Severity of frontal white matter damage in Alzheimer’s disease is closely related to 
parenchymal Abeta load (Chalmers et al., 2005). Recent studies in E280A- PSEN1 mutation 
carriers taken from the same population studied here show that Abeta deposits in frontal 
regions begin at the age of 27 (26.2–28.9) and reach a plateau at the age of 36.2 years (35.1–
39.3) (Fleisher et al., 2012). This is more than 10 years before the average age of onset of this 
form of familial Alzheimer’s disease. Of note, this is precisely the age at which we first see 
STM binding deficits in asymptomatic carriers of this mutation (Parra et al., 2010; 2011), 
supporting the notion that these events, i.e. Abeta load, white matter degeneration and STM 
binding deficits, may be associated. However, contrary to our predictions, white matter 
integrity in the investigated ROI did not correlate with STM binding performance in the 
preclinical stages of familial Alzheimer’s disease. This raises the question of what disease 
mechanism could trigger such an early memory decline. A potential account could be offered 
by the Neuroplasticity Hypothesis of Alzheimer’s disease (Teter and Ashford, 2002). Early 
amyloidosis in the course of Alzheimer’s disease may disrupt synaptic transmission leading 
to neuronal connectivity impairments (Spires-Jones and Hyman, 2014). White matter 
synaptic disruption precedes both white matter tract anomalies and neurodegeneration (Alix 
and Domingues, 2011; Sheng et al., 2012). Therefore, different memory binding functions 
may be affected by different white matter events which would range from early synaptic 
dysfunction (conjunctive binding functions) to large scale network disruptions (relational 
binding functions). Such a hypothesis will benefit from future animal and human research. 
Previous studies have reported that reduced white matter integrity in Alzheimer’s disease 
leads to a disruption of the topological organization of large-scale structural networks (Lo et 
al., 2010). We found that damage in mFWM and gCC were both related to poor performance 
on the STM binding task. The gCC is a major white matter structure hosting tracts (e.g., 
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forceps minor) which connect the dorso-lateral prefrontal cortex across hemispheres (Barbas 
and Pandya, 1984). The strength of such connectivity seems to reflect changes in response to 
task demands (Tang et al., 2010) or training (Takeuchi et al., 2010). In the context of the 
present study, the association between poor performance on the binding condition of the STM 
task and increased Dboth in regional and trans-hemispheric white matter tracks may well 
reflect the demands for top-down attentional control. A recent fMRI study which used the 
same STM binding task as the current investigation reported binding-specific activation in 
posterior parietal regions (Parra et al., 2014) which are also known to be part of the network 
supporting top-down attentional control (Gazzaley and Nobre, 2012). Therefore, the 
hypothesis that STM binding deficits may be explained, at least in part, by impaired structural 
connectivity early in the course of familial Alzheimer’s disease seems to be one supported by 
these data. 
This study also sheds light on the neural substrate of PAL deficits in Alzheimer’s disease and 
demonstrates that lower white matter integrity in frontal regions (mFWM) and in the 
hippocampal part of cingulum bundle (CGH) accounts for a significant proportion of variance 
of performance on the PAL task in symptomatic carriers of the mutation. In line with previous 
studies, the patients with familial Alzheimer’s disease assessed in the present study presented 
with associative learning deficits (Didic et al., 2011; Lowndes and Savage, 2007). 
Associative memory, also known as relational binding (Mayes et al., 2007; Moses and Ryan, 
2006), appears to rely on the integrity of grey matter located in frontal regions and the 
hippocampus (Cer and O'Reilly, 2006) as well as on the effective connectivity between these 
regions (Fellgiebel and Yakushev, 2011; Yassa, 2011). There is evidence that associative 
learning declines in the prodromal stages of late-onset sporadic Alzheimer’s disease (Fowler 
et al., 2002; Swainson et al., 2001). Previous neuroimaging studies in this population have 
demonstrated functional reorganization of medial temporal lobe structures, including the 
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hippocampus, when asymptomatic carriers with an average age of 33.7 years completed a 
face-name association task (Quiroz et al., 2010). The authors suggested that functional 
changes within the hippocampal memory system occur years before cognitive decline in 
familial Alzheimer’s disease. In fact, Parra et al. (2010; 2011) showed that STM binding and 
PAL exhibit a gradual and continued decline in groups of carriers whose age approached the 
average age of onset of this familial Alzheimer’s disease variant. This decline stood out from 
the neuropsychological background and was found to be earlier and much steeper in the 
former function. The results presented here suggest that these very early PAL impairments in 
the early stages of familial Alzheimer’s disease are not solely due to the impact of 
neurodegeneration on grey matter structures (see Quiroz et al., 2013), but also to lower white 
matter integrity of those tracts connecting them. 
It is worth noting that the analysis of DT-MRI metrics during PAL task performance revealed 
that this function relies on a more extended network than VSTM binding (Table 4). In 
previous studies we have found that STM binding was specifically affected by Alzheimer’s 
disease relative to other non-Alzheimer’s disease dementias (Della Sala et al., 2012). We 
have suggested that a potential cause for this high specificity may lie at a neuroanatomical 
level. We have recently demonstrated that normal performance on the STM binding task 
presented here does not require an intact hippocampus (Parra et al., 2013; 2014). In fact, we 
previously showed that performance on the STM binding and PAL tasks did not correlate in 
carriers of the mutations E280A- PSEN1 (Parra et al., 2011). However, associative learning 
does decline in other non-Alzheimer’s disease dementias (Clague et al., 2005; Dimitrov et 
al., 1999; Taylor et al., 1990) and also in healthy ageing (Naveh-Benjamin et al., 2007; Old 
and  Naveh-Benjamin, 2008) rendering this task less specific both for the early detection of 
Alzheimer’s disease and its differential diagnosis. In the present study we found that these 
functions previously dissociated at behavioural and anatomical level, also dissociate when the 
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integrity of white matter structure is considered, reinforcing the notion that memory binding 
functions in STM and in LTM have different neural correlates. The fact that PAL relies on a 
widespread network whereas the STM binding relies on more restricted network may well 
explain the different pattern of sensitivity and specificity shown by these two memory 
binding functions.   
A question which may arise from this study is whether the associations between lower white 
matter integrity and specific memory impairments reported here are typical of Alzheimer’s 
disease or a phenotypic expression of this specific mutation (i.e., E280A- PSEN1). There is 
no straightforward answer to this question as the links between genotype and phenotype in 
Alzheimer’s disease are poorly understood (Holmes, 2002). However, a recent study suggests 
that when it comes to STM binding, sporadic and familial variants of Alzheimer’s disease 
share a common phenotype (Parra et al., 2011). Moreover, the findings of DT-MRI studies of 
both sporadic and familial variants have been complementary suggesting that though 
triggered by different mechanisms, the clinical expression of white matter damage in these 
forms of Alzheimer’s disease may also share phenotypic features (see Gold et al., 2012).  
We acknowledge some limitations of this study. First, we used ROI analyses which introduce 
some subjective components to the placement of ROI structures of interest. However, we 
took great care in both the selection of ROIs and their placement, while checks were 
performed to ensure ROIs were placed solely in white matter structures. Furthermore, we 
assessed the inter-rater reliability as reported in a previous study (Pettit et al., 2013) and this 
analysis confirmed a high reliability of this methods. We therefore consider it unlikely that 
issues related to the placement of ROIs may have had an influence on the results reported 
here. Second, the lack of associations between memory binding performance and DT-MRI 
metrics in asymptomatic carriers may reflect limited power due to the relative small sample 
assessed in this study. This is supported by the finding of middle to large effect sizes for the 
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correlational analyses between PAL performance and DTI-metrics in this group. Finally, it is 
worth mentioning some technical difficulties we encountered in identifying ROI such as the 
fornix, which is proving relevant as a biomarker for Alzheimer’s disease (Oishi and Lyketsos, 
2014). Although we failed to find significant associations between white matter integrity in 
the selected theory-driven ROI and STM binding performance in the preclinical stages of 
familial Alzheimer’s disease, there may still be white matter structures which are relevant to 
this cognitive function. Nevertheless, we have provided reliable evidence of dissociation 
between the integrity of white matter structures and the two memory functions investigated 
here, namely STM binding and associative learning. 
In sum, the present study showed that reduced white matter integrity, in frontal lobes, corpus 
callosum and medial temporal lobes, can account for memory binding impairments in 
familial Alzheimer’s disease. In the early stages of familial Alzheimer’s disease, white matter 
integrity explained deficits in memory binding functions which rely on large scale networks 
such as PAL. However, deficits in memory binding functions which need more selective 
networks do not seem to be accounted for by white matter disruption in asymptomatic 
individuals who will unequivocally develop familial Alzheimer’s disease. Future studies 
should investigate what particular disease mechanisms underpin such an early memory 
decline. 
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Figure Captions 
 
Figure 1 Shape-colour binding task (A) Shapes used as stimuli (B) The three conditions used 
in the task 
 
Figure 2 (A) Procedures for obtaining FA and D values for each ROI (B) ROIs meeting the 
criteria set for our study: (a) genu corpus callosum- GCC,  (b) splenium corpus callosum- 
SCC,  (c) middle frontal white matter – mFWM,  (d) inferior frontal white matter – iFWM,  
(e) hippocampal part of the cingulum bundle – CGH,  and (f) centrum semiovale – CS See 
Methods for a detailed description 
  
Figure 3 Fitted regression lines for the Shape-Colour Binding (upper panel) and the Paired 
Associates Learning task (middle and lower panel) and DT-MRI variables for each group 
separately (HC = healthy controls, AC = asymptomatic carriers, FAD = familial Alzheimer's 
disease) in the regions where significant correlations between DT-MRI metrics and memory 
performance were found Dots show the observed data in raw values and lines represent fitted 
regression lines. 
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Table 1 Demographic variables and cognitive screening. 
 
 FAD 
(n = 19) 
AC 
(n = 18) 
HC 
(n = 21) 
ANOVA Post-hoc t tests (P) 
 
M (SD), (Range) M (SD), (Range) M (SD), (Range) 
F,  
P-value 
FAD vs HC AC vs HC FAD vs AC 
Age 47.5 (6.4), (38-66) 35.1 (5.5), (24-43) 39.3 (83), (25-54) 15.46  
(< 0.001) 
0.001 0.137 < 0.001 
Education 7.3 (3.7), (2-14) 10.2 (3.9), (2-16) 10.3 (27), (4-13) 4.50 
(<0.005) 
0.024 0.993 0.038 
 
MMSE  23.6 (4.3), (17-30) 29.8 (0.4), (29-30) 29.6 (07), (28-30) 39.41  
(< 0.001) 
< 0.001 0.957 < 0.001 
AC = asymptomatic carriers, FAD = Familial Alzheimer’s disease, HC = healthy controls, 
MMSE – Mini Mental State Examination 
Significant (p < 0.05) tests highlighted in grey 
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Table 2 Neuropsychological performance for the 3 groups Beta values shown are 
standardized P-values for R² are FDR-corrected 
Model  (task ~ age + education + group) Predictor  
(beta and P values) 
Post-hoc t tests 
(t and P values) 
 
Task 
R²  
(P value) 
Age Education 
Group 2  
(AC) 
Group 3 
(FAD) 
HC vs  
AC 
HC vs 
FAD 
AC vs FAD 
PAL 
0.47 
(< 0.001) 
-0.2 
(0.108) 
0.2 
(0.130) 
-0.2 
(0.438) 
-9.6 
(< 0.001) 
0.8 
(0.72) 
-4.4 
(< 0.001) 
3.3  
(0.005) 
Complex Rey Figure – copy 
0.30 
(< 0.001) 
-0.2 
(0.221) 
0.2 
(0.159) 
-0.02 
(0.939) 
-7.0 
(0.011) 
0.08 
(0.997) 
2.7 
(0.03) 
2.3 
(0.06) 
Complex Rey Figure - recall 
0.55 
(< 0.001) 
-0.01 
(0.953) 
0.2 
(0.090) 
0.07 
(0.686) 
-1.19  
(< 0.001) 
-0.4 
(0.913) 
5.6 
(< 0.001) 
5.3  
(< 0.001) 
Letter fluency (FAS) 
 
0.09 
(0.068) 
- - - - – – – 
Animal fluency 
0.32 
(< 0.001) 
0.3 
(0.059) 
0.3 
(0.036) 
0.3 
(0.209) 
-9.0  
(0.001) 
-1.3 
(0.417) 
3.5  
(0.003) 
4.1  
(< 0.001) 
Boston naming test 
0.35 
(< 0.001) 
0.2 
(0.105) 
0.3 
(0.04) 
0.2 
(0.475) 
-10.0  
(< 0.001) 
-0.7 
(0.753) 
3.9  
(< 0.001) 
4.1  
(< 0.001) 
Word list - immediate recall 
0.45 
(< 0.001) 
< 0.01 
(1.000) 
0.02 
(0.847) 
0.1 
(0.493) 
-12.1  
(< 0.001) 
-0.7 
(0.771) 
5.2 
(< 0.001) 
5.2  
(< 0.001) 
Word list - delayed recall 
0.63 
(< 0.001) 
0.1 
(0.449) 
-0.01 
(0.913) 
-0.04 
(0.830) 
-15.6 
(< 0.001) 
0.2 
(0.975) 
8.2  
(< 0.001) 
7.2  
(< 0.001) 
Word list recognition 
0.54 
(< 0.001) 
-0.1 
(0.593) 
-0.1 
(0.423) 
-0.01 
(0.960) 
-13.5 
(< 0.001) 
0.05 
(0.999) 
6.3  
(< 0.001) 
5.6  
(< 0.001) 
Trail Making Test A 
0.38 
(< 0.001) 
0.3 
(0.059) 
-0.2 
(0.047) 
0.1 
(0.827) 
6.39 
(0.009) 
-0.2 
(0.974) 
-2.7 
(0.025) 
-2.1 
(0.093) 
WCST number of categories 
0.24 
(0.002) 
0.1 
(0.320) 
0.2 
(0.164) 
0.5 
(0.030) 
-6.3 
(0.035) 
-2.2 
(0.075) 
2.2 
(0.087) 
3.6  
(0.002) 
WCST attempt to category 
-0.07 
(0.967) 
- - - - – – – 
 
Conditions of the VSTM Binding Task 
 
 
 
Shape only 
0.57 
(< 0.001) 
-0.2 
(0.077) 
0.04 
(0.697) 
-0.3 
(0.062) 
-13.7 
(< 0.001) 
1.9 
(0.147) 
6.4  
(< 0.001) 
4.3  
(< 0.001) 
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Colour only 
0.37 
(< 0.001) 
-0.1 
(0.333) 
0.07 
(0.529) 
-0.2 
(0.281) 
-11.0 
(< 0.001) 
1.1 
(0.525) 
4.3 
(< 0.001) 
3.0 
(0.01) 
 
Shape-colour binding 
0.42 
(< 0.001) 
-0.1 
(0.458) 
0.1 
(0.242) 
-0.68 
(0.001) 
-12.6 
(< 0.001) 
3.5 
(0.003) 
5.0  
(< 0.001) 
2.0 
(0.133) 
 
AC = asymptomatic carriers, FAD = Familial Alzheimer’s disease, HC = healthy controls, 
WCST = Wisconsin Card Sorting Test Significant (p<005) tests highlighted in grey 
 
 
 
 47 
 
Table 3 Significant group differences in DT-MRI measures in regions of interests P-values 
for R² are FDR-corrected 
Model (DT-MRI ~ group) Predictor  
(beta and P values) 
Post-hoc t tests 
(t and P values) 
 
 DT-MRI 
R²  
(P value) 
Group 2  
(AC) 
Group 3  
(FAD) 
HC vs  
AC 
HC  vs  
FAD 
AC vs  
FAD 
FA left mFWM 
0.04 
(0.224) 
- - - - - 
FA right mFWM 
0.007 
(0.417) 
- - - - - 
FA left iFWM 
0.03 
(0.224) 
- - - - - 
FA right iFWM 
-0.005 
(0.495) 
- - - - - 
FA left gCC 
0.06 
(0.133) 
- - - - - 
FA right gCC 
-0.01 
(0.568) 
- - - - - 
FA left sCC 
-0.03 
(0.850) 
- - - - - 
FA right sCC 
-0.01 
(0.527) 
- - - - - 
FA left CGH 
0.10 
(0.069) 
- - - - - 
FA right CGH 
0.03 
(0.224) 
- - - - - 
FA left CS 
-0.003 
(0.481) 
- - - - - 
FA right CS 
0.06 
(0.146) 
- - - - - 
Dleft mFWM 
0.07 
(0.133) 
- - - - - 
Dright mFWM 
0.08 
(0.096) 
- - - - - 
Dleft iFWM 0.15 0.04 0.76 -0.2 -3.1 -2.9 
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(0.024) (0.861) (0.003) (0.983) (0.008) (0.016) 
Dright iFWM 
0.03 
(0.234) 
- - - - - 
Dleft gCC 
0.14 
(0.024) 
0.07 
(0.781) 
0.8 
(0.003) 
-0.3 
(0.958) 
-3.1 
(0.008) 
-2.8 
(0.020) 
Dright gCC 
0.13 
(0.036) 
-0.01 
(0.969) 
0.70 
(0.007) 
0.04 
(0.999) 
-2.8 
(0.018) 
-2.8 
(0.020) 
Dleft sCC 
0.15 
(0.024) 
-0.2 
(0.409) 
0.63 
(0.012) 
0.8 
(0.685) 
-2.6 
(0.032) 
-3.3 
(0.004) 
Dright sCC 
0.005 
(0.417) 
- - - - - 
Dleft CGH 
0.16 
(0.024) 
0.3 
(0.287) 
0.85 
(0.001) 
-1.1 
(0.533) 
-3.5 
(0.003) 
-2.4 
(0.054) 
Dright CGH 
0.24 
(0.005) 
-0.1 
(0.693) 
0.86 
(< 0.001) 
0.4 
(0.917) 
-3.7 
(0.001) 
-4.0 
(< 0.001) 
Dleft CS 
0.11 
(0.055) 
- - - - - 
Dright CS 
0.005 
(0.417) 
- - - - - 
D = Mean Diffusivity, AC = asymptomatic carriers, CGH = hippocampal part of cingulum 
bundle, CS = centrum semiovale, FA = Fractional Anisotropy, FAD = Familial Alzheimer’s 
disease, gCC = genu of corpus callosum, HC = healthy controls, iFWM = inferior frontal 
white matter, mFWM = middle frontal white matter, sCC = splenium  of corpus callosum  
Significant (p<005) tests highlighted in grey  
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Table 4 Variance explained by DT-MRI parameters in task performance in the short-term 
memory binding task and the PAL task P-values are FDR-corrected 
Model (task ~ DT-MRI) VSTM Shape-Colour Binding  PAL 
 FA D FA D  
 R² (P value),  Beta R² (P value),  Beta R² (P value),  Beta R² (P value),  Beta  
Left mFWM 0.04 (0.157),  0.23 0.01 (0.276),  -0.18 0.18 (0.007),  0.44 0.14 (0.012),  -0.40  
Right mFWM 0.05 (0.102),  0.27 0.02 (0.257),  0.19 0.02 (0.243),  0.20 0.20 (0.007),  -0.46  
Left iFWM -0.02 (0.951),  0.009 0.10 (0.040),  -0.34 0.00 (0.371),  0.15 0.17 (0.007),  -0.43  
Right iFWM -0.00 (0.437),  -0.13 0.08 (0.064),  -0.31 0.01 (0.325),  0.16 0.06 (0.096),  -0.27  
Left gCC -0.00 (0.414),  0.14 0.15 (0.009),  -0.41 0.05 (0.115),  0.25 0.22 (0.007),  -0.48  
Right gCC -0.01 (0.501),  0.11 0.16 (0.009),  -0.42 -0.01 (0.501),  0.11 0.17 (0.007),  -0.43  
Left sCC -0.02 (0.728),  0.06 0.03 (0.182),  -0.22 0.06 (0.094),  0.27 0.18 (0.024),  -0.45  
Right sCC -0.01 (0.501),  0.07 -0.02 (0.734),  -0.06 0.10 (0.032),  0.35 0.09 (0.040),  -0.33  
Left CGH -0.00 (0.414),  0.14 0.15 (0.009),  -0.41 0.13 (0.015),  0.39 0.20 (0.007),  -0.46  
Right CGH 0.05 (0.112),  0.26 0.08 (0.066),  -0.31 0.05 (0.107),  0.26 0.18 (0.007),  -0.44  
Left CS -0.02 (0.782),  -0.05 0.06 (0.094),  -0.28 -0.02 (0.857),  0.03 0.15 (0.009),  -0.41  
Right CS 0.01 (0.325),  0.17 0.01 (0.299),  -0.18 0.07 (0.071),  0.29 0.07 (0.007),  -0.30  
D = Mean Diffusivity, CGH = hippocampal part of cingulum bundle, CS = centrum 
semiovale, FA = Fractional Anisotropy, gCC = genu of corpus callosum, iFWM = inferior 
frontal white matter, mFWM = middle frontal white matter, sCC = splenium  of corpus 
callosum  Significant (p<005) tests highlighted in grey 
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Supplementary Material 
 
Supplementary Table 1. All the MNI coordinates for each of the ROI used in the analysis 
 
 
  MNI coordinates 
ROI Side x, y, z x, y, z x, y, z x, y, z x, y, z x, y, z 
mFWM left -19, 37, 1 -26, 37, 1 -23, 44, 1 -19, 35, 8 -26, 35, 8 -21, 42, 8 
 right 20, 37, 1 27, 37, 1 24, 44, 1 20, 35, 8 27, 35, 8 24, 42, 8 
gCC left -10, 29, 10 -8, 30, 3     
 right 10, 30, 10 9, 30, 3     
sCC left -12, -44, 12 -10, -41, 19     
 right 15, -44, 12 12, -41, 19     
iFWM left -37, 15, 20 -37, 20, 15 -43, 11, 10    
 right 37, 15, 20 37, 20, 15 45, 12, 10    
CGH left -21,-34, -12 -21,-28,-17 -24, -24, -22    
 right 24,-31, -12 23,-26,-17 24, -22, -22    
CS left -22, 10, 36 -24, 0, 36 -26, -10, 36 -28, -20, 36 -26, -30, 36 -24,-40, 36 
 right 22, 10, 36 24, 0, 36 26, -10, 36 28, -20, 36 26, -30, 36 24, -40, 36 
 
CGH = hippocampal part of the cingulum bundle, CS = centrum semiovale, gCC = genu of 
corpus callosum, iFWM = inferior frontal white matter, mFWM = middle frontal white 
matter, sCC = splenium of corpus callosum. 
 
 
 
 
Supplementary Table 2. Procedures followed for placement of ROI. 
 
ROI 
Box size 
(voxels) 
No. of boxes 
Total size 
(voxels) 
Total size 
(mm3) 
mFWM 3 x 3 x 1 6 108 957.13 
gCC 
3 x 3 x 1 3 54 478.56 
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sCC 
3 x 3 x 1 3 54 478.56 
iFWM 3 x 3 x 1 3 54 478.56 
CGH 
3 x 3 x 1 3 54 478.56 
CS 
3 x 3 x 1 6 108 957.13 
 
CGH = hippocampal part of the cingulum bundle, CS = centrum semiovale, gCC = genu of 
corpus callosum, iFWM = inferior frontal white matter, mFWM = middle frontal white 
matter, sCC = splenium of corpus callosum. 
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Supplementary Table 3. Correlational analyses between behavioural variables and DT-MRI 
metrics for the three groups. 
Correlation between Shape-Colour Binding and DT-MRI 
 
 
HC AC FAD 
ROI r P (FDR-corrected) Cohen-d r P (FDR-corrected) Cohen-d r P (FDR-corrected) Cohen-d 
MD right mFWM 0.44 0.9620 0.98 -0.19 0.6992 0.40 -0.80 0.0365 2.65 
MD left gCC 0.23 0.9620 0.47 0.27 0.5126 0.55 -0.75 0.0400 2.25 
          Correlation between PAL and DT-MRI 
 
 
HC AC FAD 
ROI r P (FDR-corrected) Cohen-d r P (FDR-corrected) Cohen-d r P (FDR-corrected) Cohen-d 
FA left mFWM -0.14 0.9620 0.29 0.41 0.3154 0.90 0.85 0.0024 3.28 
MD left mFWM 0.19 0.9620 0.39 -0.44 0.2622 0.97 -0.70 0.0365 1.95 
MD right mFWM -0.01 0.9620 0.02 -0.46 0.2622 1.02 -0.66 0.0480 1.77 
MD left iFWM 0.07 0.9620 0.13 -0.35 0.3634 0.75 -0.70 0.0365 1.98 
MD left CGH -0.02 0.9620 0.03 -0.46 0.2622 1.05 -0.72 0.0365 2.06 
          
 
 
